"/> DiscoverX Troglitazone | B-LABO France

DiscoverX Troglitazone

Réf. : BL-RE-170237Réf. fabricant : 17312469 5 mg
478,50 € HT

Troglitazone is an agonist for PPARγ Provided as 5mg of dry powder.

Quantité
5 mg
Marque
DiscoverX

Troglitazone is a selective agonist of the peroxisome proliferator-activated receptor-γ (PPARγ) with no activity for PPARα or PPARΔ. Troglitazone is a synthetic antidiabetic and anti-inflammatory drug previously prescribed to patients with type 2 diabetes mellitus, but was withdrawn from the market in 2000 due to toxicity issues. Provided as 5mg of dry powder.

Caractéristiques techniques

MarqueDiscoverX
Réf. B-LABOBL-RE-170237
Réf. fabricant17312469
Quantité5 mg
Une question, une configuration particulière ?
Contactez-nous pour un devis.